-transparent.png){kind=logo}
The effect of nifedipine, a calcium antagonist on fasting blood glucose level, glucose tolerance, glucose-induced insulin and glucagon secretion was studied in healthy nondiabetic volunteers. Nifedipine 10mg twice daily for four weeks did not affect fasting blood glucose level, glucose tolerance, glucose-induced insulin and glucagon secretion.
Related Publications
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
June 1987,
British journal of clinical pharmacology,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
August 1988,
Journal of clinical pharmacy and therapeutics,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
November 1986,
The Journal of the Association of Physicians of India,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
August 1988,
Angiology,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
November 2009,
Journal of diabetes science and technology,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
January 2006,
The American journal of Chinese medicine,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
January 1984,
European journal of drug metabolism and pharmacokinetics,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
January 1990,
European journal of clinical pharmacology,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
January 1972,
The Journal of clinical pharmacology and new drugs,
A K Purohit, and
J D Raval, and
G F Shah, and
T P Gandhi, and
R N Gibert
May 1970,
Klinische Wochenschrift,
